Skip to content
Wednesday, November 11, 2026
Orbit Dynasty

The Zimbabwean Government Turns Down ‘One-Sided’ American Healthcare Assistance Deal Over Information Concerns

Health aid illustration
The proposed American funding was aimed at programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has rejected a major American health deal valued at 367 million US dollars (272 million pounds) over five years over the United States' demand for confidential data.

The decision came to light following a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".

An official spokesperson later clarified that the United States was demanding access to health data for scientific study and commercial purposes while was unwilling to guarantee the resulting advantages from future treatments.

"We will now turn to the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the US had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has appealed for continued talks to secure a deal agreeable to all parties so the country's vital HIV programme can continue.

Wider Background

This rejection comes after a comparable case in neighbouring Kenya, where a high court suspended a related health funding agreement following concerns were raised about the safety of citizens' medical information.

After resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

The agency had overseen assistance for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing direct bilateral agreements to boost openness and accountability.

According to reports, Sixteen African countries have to date agreed to these new health pacts, constituting more than $18.3bn in committed funds.

Specifics of the Rejected Deal

The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this partnership would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via American-funded initiatives," Tremont said.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".

"Our nation was requested to share its genetic material and health information for a long time, with no corresponding guarantee of access to any scientific breakthroughs – like new medicines or tests – that might result from that shared data," he stated.

"Put simply, our nation would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be accessible to our population if a new disease outbreak arise."

Sovereignty and International Frameworks

Mangwana further noted that the US's withdrawal from the global health body and its push of one-on-one deals were upending structures already set up via the international organization.

Mangwana cited its Pandemic Benefit-Sharing scheme designed to manage future pandemics.

"This framework is designed to ensure that when a country provides its data, the benefits – including medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to develop them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We are open to ongoing dialogue with our American counterparts on how subsequent collaboration could be arranged in a way that respects the sovereignty and dignity of each country."

Medical Community Reaction

Medical experts expressed it recognised the government's concerns, but urged that negotiations should continue considering a large portion of the country's Aids initiatives were funded by foreign aid.

"Where specific concerns arise, including those involving data governance or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," it said.

The situation highlights the complex challenges between accepting crucial international aid and protecting a country's data in an increasingly interconnected world.

About the author

Richard Gill

Elara Vance is a space technology journalist with a passion for exploring the frontiers of science and innovation.

Orbit Dynasty

Type to search articles.